Long noncoding RNAs in the initiation, progression, and metastasis of hepatocellular carcinoma

Non-coding RNA Research

Volumn 2, Issue 3-4, 2017, Pages 129-136

  DiStefano, Johanna K ^a  

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

Hepatocellular carcinoma; HOTAIR; HULC; lncRNAs; Long noncoding RNAs; Noncoding RNA

Indexed keywords

CYCLIN D1; HIGHLY UPREGULATED IN LIVER CANCER; HOMEOBOX TRANSCRIPT ANTISENSE RNA; LONG UNTRANSLATED RNA; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; STAT3 PROTEIN; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; UROTHELIAL ASSOCIATED CARCINOMA 1;

ANGIOGENESIS; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HUMAN; LIVER CELL CARCINOMA; METASTASIS; MICROARRAY ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 85056418018     PISSN: 24680540     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncrna.2017.11.001     Document Type: Review

References (136)

1. El-Serag, H.B., Kanwal, F., Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?. Hepatology 60 (2014), 1767–1775.
2. Mittal, S., El-Serag, H.B., Epidemiology of hepatocellular carcinoma consider the population. J Clin Gastroenterol 47:Suppl (2013), S2–S6.
3. Ilikhan, S.U., Bilici, M., Sahin, H., et al. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma. World J. Gastroenterol. 21 (2015), 6999–7007.
4. Forner, A., Llovet, J.M., Bruix, J., Hepatocellular carcinoma. Lancet 379 (2012), 1245–1255.
5. Cicinnati, V.R., Sotiropoulos, G.C., Beckebaum, S., Established and emerging therapies for hepatocellular carcinoma. Minerva Med. 101 (2010), 405–418.
6. Iyer, M.K., Niknafs, Y.S., Malik, R., et al. The landscape of long noncoding RNAs in the human transcriptome. Nat. Genet. 47 (2015), 199–208.
7. Leti, F., DiStefano, J.K., Long noncoding RNAs as diagnostic and therapeutic targets in type 2 diabetes and related complications. Genes (Basel), 2017, 8.
8. Li, L.J., Leng, R.X., Fan, Y.G., Pan, H.F., Ye, D.Q., Translation of noncoding RNAs: focus on lncRNAs, pri-miRNAs, and circRNAs. Exp. Cell Res. 361 (2017), 1–8.
9. Marchese, F.P., Raimondi, I., Huarte, M., The multidimensional mechanisms of long noncoding RNA function. Genome Biol., 18, 2017, 206.
10. Sun, W., Yang, Y., Xu, C., Guo, J., Regulatory mechanisms of long noncoding RNAs on gene expression in cancers. Cancer Genet. 216-217 (2017), 105–110.
11. Borsani, G., Tonlorenzi, R., Simmler, M.C., et al. Characterization of a murine gene expressed from the inactive X chromosome. Nature 351 (1991), 325–329.
12. Brannan, C.I., Dees, E.C., Ingram, R.S., Tilghman, S.M., The product of the H19 gene may function as an RNA. Mol. Cell Biol. 10 (1990), 28–36.
13. Brockdorff, N., Ashworth, A., Kay, G.F., et al. The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell 71 (1992), 515–526.
14. Jia, M., Jiang, L., Wang, Y.D., Huang, J.Z., Yu, M., Xue, H.Z., lincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through Notch signaling-induced epithelial-mesenchymal transition. Hepatol. Res. 46:11 (2016 Oct), 1137–1144.
15. Peng, W., Fan, H., Long noncoding RNA CCHE1 indicates a poor prognosis of hepatocellular carcinoma and promotes carcinogenesis via activation of the ERK/MAPK pathway. Biomed. Pharmacother. 83 (2016), 450–455.
16. Sui, C.J., Zhou, Y.M., Shen, W.F., et al. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429. J. Mol. Med. Berl. 94:11 (2016 Nov), 1281–1296.
17. Wang, T., Ma, S., Qi, X., et al. Long noncoding RNA ZNFX1-AS1 suppresses growth of hepatocellular carcinoma cells by regulating the methylation of miR-9. Onco Targets Ther. 9 (2016), 5005–5014.
18. Xiong, D., Sheng, Y., Ding, S., et al. LINC00052 regulates the expression of NTRK3 by miR-128 and miR-485-3p to strengthen HCC cells invasion and migration. Oncotarget 7:30 (2016 Jul 26), 47593–47608.
19. Yang, L., Zhang, X., Li, H., Liu, J., The long noncoding RNA HOTAIR activates autophagy by upregulating ATG3 and ATG7 in hepatocellular carcinoma. Mol. Biosyst. 12 (2016), 2605–2612.
20. Yu, J., Han, J., Zhang, J., et al. The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis. Med. Baltim., 95, 2016, e4436.
21. Yuan, P., Cao, W., Zang, Q., Li, G., Guo, X., Fan, J., The HIF-2alpha-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy. Biochem. Biophys. Res. Commun. 478:3 (2016 Sep 23), 1067–1073.
22. Zhou, N., Si, Z., Li, T., Chen, G., Zhang, Z., Qi, H., Long non-coding RNA CCAT2 functions as an oncogene in hepatocellular carcinoma, regulating cellular proliferation, migration and apoptosis. Oncol. Lett. 12 (2016), 132–138.
23. Zhu, X.T., Yuan, J.H., Zhu, T.T., Li, Y.Y., Cheng, X.Y., Long noncoding RNA GPC3-AS1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3. FEBS J. 12:1 (2016 Jul), 132–138.
24. Liu, W.T., Lu, X., Tang, G.H., et al. LncRNAs expression signatures of hepatocellular carcinoma revealed by microarray. World J. Gastroenterol. 20 (2014), 6314–6321.
25. Zhu, J., Liu, S., Ye, F., et al. The long noncoding RNA expression profile of hepatocellular carcinoma identified by microarray analysis. PLoS One, 9, 2014, e101707.
26. Zhang, J., Fan, D., Jian, Z., Chen, G.G., Lai, P.B., Cancer specific long noncoding RNAs show differential expression patterns and competing endogenous RNA potential in hepatocellular carcinoma. PLoS One, 10, 2015, e0141042.
27. Hua, L., Wang, C.Y., Yao, K.H., Chen, J.T., Zhang, J.J., Ma, W.L., High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma. Int. J. Clin. Exp. Pathol. 8 (2015), 3076–3082.
28. Tu, Z.Q., Li, R.J., Mei, J.Z., Li, X.H., Down-regulation of long non-coding RNA GAS5 is associated with the prognosis of hepatocellular carcinoma. Int. J. Clin. Exp. Pathol. 7 (2014), 4303–4309.
29. Yan, T.H., Yang, H., Jiang, J.H., et al. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma. Int. J. Clin. Exp. Pathol. 8 (2015), 4126–4131.
30. Bao, H., Su, H., Long noncoding RNAs act as novel biomarkers for hepatocellular carcinoma: progress and prospects. Biomed. Res. Int., 2017, 2017, 6049480.
31. Panzitt, K., Tschernatsch, M.M., Guelly, C., et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 132 (2007), 330–342.
32. Li, S.P., Xu, H.X., Yu, Y., et al. LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway. Oncotarget 7:27 (2016 Jul 5), 42431–42446.
33. Wang, J., Liu, X., Wu, H., et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 38 (2010), 5366–5383.
34. Di Bisceglie, A.M., Hepatitis B and hepatocellular carcinoma. Hepatology 49 (2009), S56–S60.
35. Kim, C.M., Koike, K., Saito, I., Miyamura, T., Jay, G., HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351 (1991), 317–320.
36. Muroyama, R., Kato, N., Yoshida, H., et al. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma. J. Hepatol. 45 (2006), 805–812.
37. Du, Y., Kong, G., You, X., et al. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J. Biol. Chem. 287 (2012), 26302–26311.
38. Hammerle, M., Gutschner, T., Uckelmann, H., et al. Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1). Hepatology 58 (2013), 1703–1712.
39. Lu, Z., Xiao, Z., Liu, F., et al. Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1). Oncotarget 7 (2016), 241–254.
40. Alvarez, S.E., Harikumar, K.B., Hait, N.C., et al. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465 (2010), 1084–1088.
41. Liu, Y., Deng, J., Wang, L., et al. S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma. Blood 120 (2012), 1458–1465.
42. Nagahashi, M., Ramachandran, S., Kim, E.Y., et al. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. Cancer Res. 72 (2012), 726–735.
43. Rinn, J.L., Kertesz, M., Wang, J.K., et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129 (2007), 1311–1323.
44. Yang, Z., Zhou, L., Wu, L.M., et al. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann. Surg. Oncol. 18 (2011), 1243–1250.
45. Geng, Y.J., Xie, S.L., Li, Q., Ma, J., Wang, G.Y., Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J. Int. Med. Res. 39 (2011), 2119–2128.
46. Ding, C., Cheng, S., Yang, Z., et al. Long non-coding RNA HOTAIR promotes cell migration and invasion via down-regulation of RNA binding motif protein 38 in hepatocellular carcinoma cells. Int. J. Mol. Sci. 15 (2014), 4060–4076.
47. Ishibashi, M., Kogo, R., Shibata, K., et al. Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. Oncol. Rep. 29 (2013), 946–950.
48. Gao, J.Z., Li, J., Du, J.L., Li, X.L., Long non-coding RNA HOTAIR is a marker for hepatocellular carcinoma progression and tumor recurrence. Oncol. Lett. 11 (2016), 1791–1798.
49. Fu, W.M., Zhu, X., Wang, W.M., et al. Hotair mediates hepatocarcinogenesis through suppressing miRNA-218 expression and activating P14 and P16 signaling. J. Hepatol. 63 (2015), 886–895.
50. Zhang, H., Xing, Z., Mani, S.K., et al. RNA helicase DEAD box protein 5 regulates Polycomb repressive complex 2/Hox transcript antisense intergenic RNA function in hepatitis B virus infection and hepatocarcinogenesis. Hepatology 64 (2016), 1033–1048.
51. Su, D.N., Wu, S.P., Chen, H.T., He, J.H., HOTAIR, a long non-coding RNA driver of malignancy whose expression is activated by FOXC1, negatively regulates miRNA-1 in hepatocellular carcinoma. Oncol. Lett. 12 (2016), 4061–4067.
52. Zhou, J.J., Cheng, D., He, X.Y., Meng, Z., Li, W.Z., Chen, R.F., Knockdown of Hotair suppresses proliferation and cell cycle progression in hepatocellular carcinoma cell by downregulating CCND1 expression. Mol. Med. Rep. 16 (2017), 4980–4986.
53. Raza, A., Sood, G.K., Hepatocellular carcinoma review: current treatment, and evidence-based medicine. World J. Gastroenterol. 20 (2014), 4115–4127.
54. Tsuchiya, N., Sawada, Y., Endo, I., Saito, K., Uemura, Y., Nakatsura, T., Biomarkers for the early diagnosis of hepatocellular carcinoma. World J. Gastroenterol. 21 (2015), 10573–10583.
55. Schraml, C., Kaufmann, S., Rempp, H., et al. Imaging of HCC-current state of the art. Diagn. (Basel) 5 (2015), 513–545.
56. Hao, Q.Q., Chen, G.Y., Zhang, J.H., Sheng, J.H., Gao, Y., Diagnostic value of long noncoding RNAs for hepatocellular carcinoma: a PRISMA-compliant meta-analysis. Med. Baltim., 96, 2017, e7496.
57. Singal, A., Volk, M.L., Waljee, A., et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment. Pharmacol. Ther. 30 (2009), 37–47.
58. Tong, M.J., Blatt, L.M., Kao, V.W., Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J. Gastroenterol. Hepatol. 16 (2001), 553–559.
59. Kobayashi, K., Sugimoto, T., Makino, H., et al. Screening methods for early detection of hepatocellular carcinoma. Hepatology 5 (1985), 1100–1105.
60. El-Serag, H.B., Davila, J.A., Surveillance for hepatocellular carcinoma: in whom and how?. Ther. Adv. Gastroenterol. 4 (2011), 5–10.
61. Zheng, C., Liu, X., Chen, L., Xu, Z., Shao, J., lncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget 8 (2017), 59638–59647.
62. Bialecki, E.S., Di Bisceglie, A.M., Diagnosis of hepatocellular carcinoma. HPB Oxf. 7 (2005), 26–34.
63. Johnson, P.J., The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin. Liver Dis. 5 (2001), 145–159.
64. Huang, Y.K., Yu, J.C., Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: an update and review. World J. Gastroenterol. 21 (2015), 9863–9886.
65. Kishikawa, T., Otsuka, M., Ohno, M., Yoshikawa, T., Takata, A., Koike, K., Circulating RNAs as new biomarkers for detecting pancreatic cancer. World J. Gastroenterol. 21 (2015), 8527–8540.
66. Shi, Q., Yang, X., Circulating MicroRNA and long noncoding RNA as biomarkers of cardiovascular diseases. J. Cell Physiol. 231 (2016), 751–755.
67. Xie, H., Ma, H., Zhou, D., Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed. Res. Int., 2013, 2013, 136106.
68. Li, J., Wang, X., Tang, J., et al. HULC and Linc00152 act as novel biomarkers in predicting diagnosis of hepatocellular carcinoma. Cell Physiol. Biochem. 37 (2015), 687–696.
69. Luo, J.H., Ren, B., Keryanov, S., et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 44 (2006), 1012–1024.
70. Konishi, H., Ichikawa, D., Yamamoto, Y., et al. Plasma level of metastasis-associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinoma. Cancer Sci. 107 (2016), 149–154.
71. Kamel, M.M., Matboli, M., Sallam, M., Montasser, I.F., Saad, A.S., El-Tawdi, A.H.F., Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma. Transl. Res. 168 (2016), 134–145.
72. Zheng, Z.K., Pang, C., Yang, Y., Duan, Q., Zhang, J., Liu, W.C., Serum long noncoding RNA urothelial carcinoma-associated 1: a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma. J. Int. Med. Res., 2017, 300060517726441.
73. Lu, X., Zhou, C., Li, R., et al. Critical role for the long non-coding RNA AFAP1-AS1 in the proliferation and metastasis of hepatocellular carcinoma. Tumour Biol. 37 (2016), 9699–9707.
74. Zhang, J.Y., Weng, M.Z., Song, F.B., et al. Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling. Int. J. Oncol. 48 (2016), 1590–1598.
75. Wang, T.H., Lin, Y.S., Chen, Y., et al. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition. Oncotarget 6 (2015), 23342–23357.
76. Huang, M.D., Chen, W.M., Qi, F.Z., et al. Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell apoptosis by epigenetic silencing of KLF2. J. Hematol. Oncol., 8, 2015, 50.
77. Wang, F., Xie, C., Zhao, W., Deng, Z., Yang, H., Fang, Q., Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Clin. Exp. Med. 17 (2017), 33–43.
78. Deng, L., Yang, S.B., Xu, F.F., Zhang, J.H., Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge. J. Exp. Clin. Cancer Res., 34, 2015, 18.
79. Zhu, H., Zhou, X., Chang, H., et al. CCAT1 promotes hepatocellular carcinoma cell proliferation and invasion. Int. J. Clin. Exp. Pathol. 8 (2015), 5427–5434.
80. Zhu, H.Q., Zhou, X., Chang, H., et al. Aberrant expression of CCAT1 regulated by c-Myc predicts the prognosis of hepatocellular carcinoma. Asian Pac J. Cancer Prev. 16 (2015), 5181–5185.
81. Ma, X., Wang, X., Yang, C., et al. DANCR acts as a diagnostic biomarker and promotes tumor growth and metastasis in hepatocellular carcinoma. Anticancer Res. 36 (2016), 6389–6398.
82. Yuan, S.X., Wang, J., Yang, F., et al. Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1. Hepatology 63 (2016), 499–511.
83. Huang, J.L., Ren, T.Y., Cao, S.W., et al. HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma. Oncotarget 6 (2015), 33791–33804.
84. Liu, F., Yuan, J.H., Huang, J.F., et al. Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a. Oncogene 35 (2016), 5422–5434.
85. Chang, L., Li, C., Lan, T., et al. Decreased expression of long non-coding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin. Mol. Med. Rep. 13 (2016), 1541–1550.
86. Hu, L., Ye, H., Huang, G., et al. Long noncoding RNA GAS5 suppresses the migration and invasion of hepatocellular carcinoma cells via miR-21. Tumour Biol. 37 (2016), 2691–2702.
87. Zhu, X.T., Yuan, J.H., Zhu, T.T., Li, Y.Y., Cheng, X.Y., Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3. FEBS J. 283 (2016), 3739–3754.
88. Matouk, I.J., DeGroot, N., Mezan, S., et al. The H19 non-coding RNA is essential for human tumor growth. PLoS One, 2, 2007, e845.
89. Yang, F., Zhang, L., Huo, X.S., et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 54 (2011), 1679–1689.
90. Liu, Z., Wei, X., Zhang, A., Li, C., Bai, J., Dong, J., Long non-coding RNA HNF1A-AS1 functioned as an oncogene and autophagy promoter in hepatocellular carcinoma through sponging hsa-miR-30b-5p. Biochem. Biophys. Res. Commun. 473 (2016), 1268–1275.
91. Ge, Y., Yan, X., Jin, Y., et al. MiRNA-192 [corrected] and miRNA-204 directly suppress lncRNA HOTTIP and interrupt GLS1-mediated glutaminolysis in hepatocellular carcinoma. PLoS Genet., 11, 2015, e1005726.
92. Tsang, F.H., Au, S.L., Wei, L., et al. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b. Liver Int. 35 (2015), 1597–1606.
93. Wang, F., Yang, H., Deng, Z., Su, Y., Fang, Q., Yin, Z., HOX antisense lincRNA HOXA-AS2 promotes tumorigenesis of hepatocellular carcinoma. Cell Physiol. Biochem. 40 (2016), 287–296.
94. Xiong, H., Li, B., He, J., Zeng, Y., Zhang, Y., He, F., lncRNA HULC promotes the growth of hepatocellular carcinoma cells via stabilizing COX-2 protein. Biochem. Biophys. Res. Commun. 490 (2017), 693–699.
95. Xiong, H., Ni, Z., He, J., et al. LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells. Oncogene 36 (2017), 3528–3540.
96. Ji, J., Tang, J., Deng, L., et al. LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway. Oncotarget 6 (2015), 42813–42824.
97. Wang, X., Zhang, W., Tang, J., et al. LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway. Cell Death Dis., 7, 2016, e2130.
98. Tang, J., Zhuo, H., Zhang, X., et al. A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma. Cell Death Dis., 5, 2014, e1549.
99. Gao, Y., Wang, G., Zhang, C., et al. Long non-coding RNA linc-cdh4-2 inhibits the migration and invasion of HCC cells by targeting R-cadherin pathway. Biochem. Biophys. Res. Commun. 480 (2016), 348–354.
100. Ding, G., Peng, Z., Shang, J., Kang, Y., Ning, H., Mao, C., LincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through miR-9/E-cadherin cascade signaling pathway molecular mechanism. Onco Targets Ther. 10 (2017), 3241–3247.
101. Xu, J.H., Chang, W.H., Fu, H.W., Shu, W.Q., Yuan, T., Chen, P., Upregulated long non-coding RNA LOC90784 promotes cell proliferation and invasion and is associated with poor clinical features in HCC. Biochem. Biophys. Res. Commun. 490 (2017), 920–926.
102. Yuan, J.H., Yang, F., Wang, F., et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 25 (2014), 666–681.
103. Ding, L.J., Li, Y., Wang, S.D., et al. Long noncoding RNA lncCAMTA1 promotes proliferation and cancer stem cell-like properties of liver cancer by inhibiting CAMTA1. Int. J. Mol. Sci., 2016, 17.
104. Wang, Y., He, L., Du, Y., et al. The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. Cell Stem Cell 16 (2015), 413–425.
105. Wu, J., Zhang, J., Shen, B., et al. Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition. J. Exp. Clin. Cancer Res., 34, 2015, 116.
106. Lai, M.C., Yang, Z., Zhou, L., et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med. Oncol. 29 (2012), 1810–1816.
107. Fang, L., Sun, J., Pan, Z., et al. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IkappaB. Am. J. Physiol. Gastrointest. Liver Physiol. 313 (2017), G150–G156.
108. Peng, W., Fan, H., Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma. Biomed. Pharmacother. 72 (2015), 113–118.
109. Wen, J., Xu, J., Sun, Q., Xing, C., Yin, W., Upregulation of long non coding RNA PCAT-1 contributes to cell proliferation, migration and apoptosis in hepatocellular carcinoma. Mol. Med. Rep. 13 (2016), 4481–4486.
110. Dong, L., Ni, J., Hu, W., Yu, C., Li, H., Upregulation of long non-coding RNA PlncRNA-1 promotes metastasis and induces epithelial-mesenchymal transition in hepatocellular carcinoma. Cell Physiol. Biochem. 38 (2016), 836–846.
111. Wang, F., Yuan, J.H., Wang, S.B., et al. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatology 60 (2014), 1278–1290.
112. Zhang, H., Zhou, D., Ying, M., et al. Expression of long non-coding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) exacerbates hepatocellular carcinoma through suppressing miR-195. Med. Sci. Monit. 22 (2016), 4820–4829.
113. Zhang, M., Wang, W., Li, T., et al. Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis. Biomed. Pharmacother. 80 (2016), 73–79.
114. Cao, C., Zhang, T., Zhang, D., et al. The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma. Oncogene 36 (2017), 1112–1122.
115. Shi, X.M., Teng, F., Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Int. J. Clin. Exp. Pathol. 8 (2015), 4008–4014.
116. Zhou, M., Zhang, X.Y., Yu, X., Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Biomed. Pharmacother. 85 (2017), 348–354.
117. Li, S., Huang, Y., Huang, Y., et al. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation. J. Exp. Clin. Cancer Res., 36, 2017, 51.
118. Huang, M.D., Chen, W.M., Qi, F.Z., et al. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2. Mol. Cancer, 14, 2015, 165.
119. Wang, Y., Liu, Z., Yao, B., et al. Long non-coding RNA TUSC7 acts a molecular sponge for miR-10a and suppresses EMT in hepatocellular carcinoma. Tumour Biol. 37 (2016), 11429–11441.
120. Pan, Y., Qin, T., Yin, S., Zhang, X., Gao, X., Mu, L., Long non-coding RNA UC001kfo promotes hepatocellular carcinoma proliferation and metastasis by targeting alpha-SMA. Biomed. Pharmacother. 87 (2017), 669–677.
121. Ni, W., Zhang, Y., Zhan, Z., et al. A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1. J. Hematol. Oncol., 10, 2017, 91.
122. Bo, C., Li, N., Li, X., Liang, X., An, Y., Long noncoding RNA uc.338 promotes cell proliferation through association with BMI1 in hepatocellular carcinoma. Hum. Cell 29 (2016), 141–147.
123. Hu, J.J., Song, W., Zhang, S.D., et al. HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling. Sci. Rep., 6, 2016, 23521.
124. Xiao, J.N., Yan, T.H., Yu, R.M., et al. Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression. J. Cancer Res. Clin. Oncol. 143 (2017), 981–990.
125. Cao, C., Sun, J., Zhang, D., et al. The long intergenic noncoding RNA UFC1, a target of MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of beta-catenin in HCC cells. Gastroenterology, 148, 2015, e18 415–426.
126. Lv, J., Fan, H.X., Zhao, X.P., et al. Long non-coding RNA Unigene56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells. Cancer Lett. 382 (2016), 166–175.
127. Xu, W.H., Zhang, J.B., Dang, Z., et al. Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK/MAPK signaling pathway in hepatocellular carcinoma. Int. J. Biol. Sci. 10 (2014), 664–676.
128. Zhuang, L.K., Yang, Y.T., Ma, X., et al. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST. Cell Death Dis., 7, 2016, e2203.
129. Lan, T., Chang, L., Wu, L., Yuan, Y., Downregulation of ZEB2-AS1 decreased tumor growth and metastasis in hepatocellular carcinoma. Mol. Med. Rep. 14 (2016), 4606–4612.
130. Li, T., Xie, J., Shen, C., et al. Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma. Oncogene 35 (2016), 1575–1584.
131. Li, T., Xie, J., Shen, C., et al. Amplification of long noncoding RNA ZFAS1 promotes metastasis in hepatocellular carcinoma. Cancer Res. 75 (2015), 3181–3191.
132. Huang, R., Wang, X., Zhang, W., et al. Down-regulation of LncRNA DGCR5 correlates with poor prognosis in hepatocellular carcinoma. Cell Physiol. Biochem. 40 (2016), 707–715.
133. Tang, J., Jiang, R., Deng, L., Zhang, X., Wang, K., Sun, B., Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma. Oncotarget 6 (2015), 4505–4515.
134. Jing, W., Gao, S., Zhu, M., et al. Potential diagnostic value of lncRNA SPRY4-IT1 in hepatocellular carcinoma. Oncol. Rep. 36 (2016), 1085–1092.
135. Wang, K., Guo, W.X., Li, N., et al. Serum LncRNAs profiles serve as novel potential biomarkers for the diagnosis of HBV-positive hepatocellular carcinoma. PLoS One, 10, 2015, e0144934.
136. Lu, J., Xie, F., Geng, L., Shen, W., Sui, C., Yang, J., Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV. Tumour Biol. 36 (2015), 3231–3236.